Denmark Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Manage your social media Best social media tool for image publishing to Facebook and Twitter. Look amazing and delight your followers. Get 40% off when you sign up today. From our sponsors

Denmark Pharmaceuticals and Healthcare Report Q4 2013 Oct 16th 2013, 00:00, by swapnil BMI View: Denmark’s pharmaceutical market is small compared with those of its Western European neighbours. However, BMI believes the country’s high public expenditure on health, stringent regulatory climate (recognised by the US and the EU) and stable, transparent business environment are major factors that make it an attractive location for drugmakers in which to set up operations. Headline Expenditure Projections ? Pharmaceuticals: DKK20.48bn (US$3.54bn) in 2012 to DKK20.21bn (US$3.61bn) in 2013; -1.3% in local currency terms and 2.0% in US dollar terms. ? Healthcare: DKK203.30bn (US$35.11bn) in 2012 to DKK208.23bn (US$37.17bn) in 2013; +2.4% in local currency terms and +5.9% … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=120558. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/denmark-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions